RSS
15 Dec 2020

Targeting the CD47-SIRPA Axis in Oncology Analytical Tool 2020: 76 Drugs in Active Development in Cancer Across 28 Different Targets

Author: admintech | Filed under: Press Release

DUBLIN, Dec. 15, 2020 /PRNewswire/ — The “Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering. Targeting the CD47-SIRPa axis is emerging as one of the most promising new cancer immunotherapy approaches seeking to target…

This entry was posted on Tuesday, December 15th, 2020 at 7:11 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»